Evidence map›Paper›PMID 32587883›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2020

Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease.

Andrew J Aschenbrenner, Jennifer Petros, Eric McDade, Guoqiao Wang, David A Balota, Tammie Ls Benzinger, Carlos Cruchaga, Alison Goate, Chengjie Xiong, Richard Perrin and 13 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. High-frequency assessment of mood, personality, and cognition in healthy younger, healthy older and adults with cognitive impairment.Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2024
    Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Early-Onset Alzheimer's Disease: What Is Missing in Research?Current neurology and neuroscience reports · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 4 countries.

Andrew J AschenbrennerCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Jennifer PetrosCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Eric McDadeCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Guoqiao WangDivision of Biostatistics Washington University School of Medicine St. Louis Missouri USA.
David A BalotaDepartment of Psychological and Brain Sciences Washington University in St. Louis St. Louis Missouri USA.
Tammie Ls BenzingerCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Carlos CruchagaCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Alison GoateDepartment of Neuroscience Icahn School of Medicine at Mount Sinai New York New York USA.
Chengjie XiongCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Richard PerrinDivision of Neuropathology Department of Pathology & Immunology Washington University School of Medicine St. Louis Missouri USA.
Anne M FaganCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Neill Graff-RadfordDepartment of Neurology Mayo Clinic Jacksonville Florida USA.
Bernardino GhettiDepartment of Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis Indiana USA.
Johannes LevinGerman Center for Neurodegenerative Diseases Munich Germany.
Endy WeidingerGerman Center for Neurodegenerative Diseases Munich Germany.
Peter SchofieldNeuroscience Research Australia Sydney New South Wales Australia.
Susanne GräberGerman Center for Neurodegenerative Diseases (DZNE) Tübingen Germany.
Jae-Hong LeeDepartment of Neurology University of Ulsan College of Medicine Asan Medical Center Seoul Korea.
Jasmeer P ChhatwalMassachusetts General Hospital Harvard Medical School Boston Massachusetts USA.
John C MorrisCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Randall BatemanCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Jason HassenstabCharles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Dominantly Inherited Alzheimer Network
Washington University in St. Louis · USHope Center for Neurological Disorders · USGerman Center for Neurodegenerative Diseases · DEHarvard University · USIcahn School of Medicine at Mount Sinai · USIndiana University School of MedicineJacksonville College · USUlsan College · KRUNSW Sydney · AU

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
Imaging CoreU19AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2010 to 2025
$53.9M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI FAGAN, ANNE · 1985 to 2019
$52.1M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI DAVID M. HOLTZMAN · 2020 to 2026
$28.7M
Dominantly Inherited Alzheimer NetworkUF1AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2014 to 2017
$21.6M
THE XNAT IMAGING INFORMATICS PLATFORMR01EB009352 · NIBIB · WASHINGTON UNIVERSITY · PI Daniel Scott Marcus · 2009 to 2026
$9.3M
Imaging CoreU01AG032438 · NIA · WASHINGTON UNIVERSITY · PI MARCUS, DANIEL SCOTT · 2008 to 2009
$6.1M
NCATS NIH HHS UL1 TR002345NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P30 AG066444NIA NIH HHS P50 AG005681NIA NIH HHS U01 AG032438NIA NIH HHS U19 AG032438NIA NIH HHS UF1 AG032438NIBIB NIH HHS R01 EB009352
6 · The paper itself

Abstract

introductionChanges in personality characteristics are associated with the onset of symptoms in Alzheimer's disease (AD) and may even precede clinical diagnosis. However, personality changes caused by disease progression can be difficult to separate from changes that occur with normal aging. The Dominantly Inherited Alzheimer Network (DIAN) provides a unique cohort in which to relate measures of personality traits to in vivo markers of disease in a much younger sample than in typical late onset AD.

methodsPersonality traits measured with the International Personality Item Pool at baseline from DIAN participants were analyzed as a function of estimated years to onset of clinical symptoms and well-established AD biomarkers.

resultsBoth neuroticism and conscientiousness were correlated with years to symptom onset and markers of tau pathology in the cerebrospinal fluid. Self-reported conscientiousness and both neuroticism and conscientiousness ratings from a collateral source were correlated with longitudinal rates of cognitive decline such that participants who were rated as higher on neuroticism and lower on conscientiousness exhibited accelerated rates of cognitive decline. DISCUSSION: Personality traits are correlated with the accumulation of AD pathology and time to symptom onset, suggesting that AD progression can influence an individual's personality characteristics. Together these findings suggest that measuring neuroticism and conscientiousness may hold utility in tracking disease progression in AD.

Identifiers

PMID32587883
PMCPMC7311802
OpenAlexW3037874710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.